| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 01/12/1995 | CA2166383A1 Pharmaceutical compositions and use thereof for treatment of neurological diseases and etiologically related symptomology |
| 01/12/1995 | CA2166380A1 Method for introducing a biological substance into a target |
| 01/12/1995 | CA2166278A1 A truncated keratinocyte growth factor (kgf) having increased biological activity |
| 01/12/1995 | CA2165789A1 Encapsulated medicine |
| 01/12/1995 | CA2143667A1 Pharmaceutical emulsions containing bioactive steroids |
| 01/11/1995 | EP0633058A1 Process for preparing spherules |
| 01/11/1995 | EP0633029A2 Further improvements relating to drug delivery systems |
| 01/11/1995 | EP0633024A1 Topically administrable zinc phthalocyanine compositions |
| 01/11/1995 | EP0633019A1 Pressurized gas packagings using polyoxyethylene glyceryl fatty acid esters as suspension stabilizers and valve lubricants |
| 01/11/1995 | EP0632729A1 Anti-zona pellucida antibodies for delivery of therapeutic agents to the ovary |
| 01/11/1995 | EP0632728A1 Preparation and use of polyanionic polymer-based conjugates targeted to vascular endothelial cells |
| 01/11/1995 | EP0632727A1 Conjugates formed from heat shock proteins and oligo- or polysaccharides |
| 01/11/1995 | EP0632722A1 A dna transporter system and method of use |
| 01/11/1995 | EP0632720A1 Alkyl-substituted cellulose-based sustained-release oral drug dosage forms |
| 01/11/1995 | EP0563227B1 Cosmetic or pharmaceutical composition in the form of a rigid gel, particularly for containing inclusions therein |
| 01/11/1995 | EP0552227B1 Orally administered solvent-free pharmaceutical preparation with delayed active-substance release, and a method of preparing the preparation |
| 01/10/1995 | US5380927 Process for preparing optically active 2-aryl-alkanoic acids, in particular 2-aryl-propionic acids |
| 01/10/1995 | US5380780 Absorbable coating and blend |
| 01/10/1995 | US5380761 Transdermal compositions |
| 01/10/1995 | US5380745 Medicinal composition |
| 01/10/1995 | US5380658 Immobilization of biologically active substances with a polyphosphazene carrier |
| 01/10/1995 | US5380536 Biocompatible microcapsules |
| 01/10/1995 | US5380519 Surfactant and stabilizer, ultrasonic images |
| 01/10/1995 | CA2126819A1 Kit and method for pretargeting |
| 01/10/1995 | CA2117399A1 Topically administrable zinc phthalocyanine compositions |
| 01/05/1995 | WO1995000638A2 Antisense oligonucleotides and therapeutic use thereof in human immunodeficiency virus infection |
| 01/05/1995 | WO1995000547A1 Antimicrobial composition of a polymer and a peptide forming amphiphilic helices of the magainin-type |
| 01/05/1995 | WO1995000540A1 Synthetic carrier and immunogen |
| 01/05/1995 | WO1995000527A1 Fucosylated glycosides as inhibitors of bacterial adherence |
| 01/05/1995 | WO1995000177A1 Pharmaceutical preparation and a method for inhibiting the replication of various viruses |
| 01/05/1995 | WO1995000158A1 Dietary supplement incorporating beta-sitosterol and pectin |
| 01/05/1995 | WO1995000152A1 Pharmaceutical composition containing heparin, heparin fragments or their derivatives in combination with glycerol esters |
| 01/05/1995 | WO1995000151A1 Absorption enhancers for drug administration |
| 01/05/1995 | WO1995000144A1 Composition for ophthalmic use |
| 01/05/1995 | WO1995000128A1 Compositions for inhalation |
| 01/05/1995 | WO1995000127A1 Therapeutic preparation for inhalation |
| 01/05/1995 | WO1995000126A1 Surface-modified albumin microspheres and pharmaceutical compositions containing them |
| 01/05/1995 | WO1995000123A1 Soft gelatin capsule shell compositions |
| 01/05/1995 | WO1995000121A1 Compressible enzyme powder |
| 01/05/1995 | WO1995000088A1 Molecular transdermal transport system |
| 01/05/1995 | WO1994022445A3 Pharmaceutical compositions for intranasal administration of dihydroergotamine, apomorphine and morphine |
| 01/05/1995 | CA2165284A1 Compressible enzyme powder |
| 01/05/1995 | CA2164961A1 Fucosylated glycosides as inhibitors of bacterial adherence |
| 01/05/1995 | CA2161781A1 Surface-modified albumin microspheres and pharmaceutical compositions containing them |
| 01/04/1995 | EP0632082A1 Preparation of activated carbamates of poly(alkylene glycol) and their use |
| 01/04/1995 | EP0631787A2 Method for suppressing bitter taste of oral preparation |
| 01/04/1995 | EP0631782A1 Stabilized solid pharmaceutical preparation containing dextromethorphan, phenylpropanolamine and caffeine |
| 01/04/1995 | EP0631781A1 Opioid formulations having extended controlled release |
| 01/04/1995 | EP0631775A1 Pharmaceutical tablet capable of releasing the active ingredients at subsequent times |
| 01/04/1995 | EP0631617A1 Colon crypt cell mitogen, cell line producing it, and uses thereof |
| 01/04/1995 | EP0631504A1 Novel medicament |
| 01/04/1995 | EP0631502A1 Lymphocyte activity regulation by hla peptides |
| 01/04/1995 | EP0563176B1 Method of producing microscopic particles made of hydrolytically decomposable polymers and containing active substances |
| 01/04/1995 | CN1027225C Pharmaceutical composition containing calcitonins and process for preparing same |
| 01/04/1995 | CN1027224C Stabilised human protein preparations |
| 01/03/1995 | US5378825 Backbone modified oligonucleotide analogs |
| 01/03/1995 | US5378730 Permeation enhancer comprising ethanol and monoglycerides |
| 01/03/1995 | US5378688 Conjugating luteinizing hormone releasing hormone to plant, bacterialo or chemical toxins |
| 01/03/1995 | US5378540 Absorbable coating and blend and suture coated therewith |
| 01/03/1995 | US5378475 Sustained release drug delivery devices |
| 01/03/1995 | US5378473 Transdermal administration of short or intermediate half-life benzodiazepines |
| 01/03/1995 | US5378472 Modified with levulinic acid |
| 01/03/1995 | US5378456 Antitumor mitoxantrone polymeric compositions |
| 01/03/1995 | CA1333775C Injectable solutions containing pyridine derivatives |
| 01/03/1995 | CA1333770C Implantable, biodegradable system for releasing active substance |
| 12/31/1994 | CA2127085A1 Stabilized solid pharmaceutical preparation and method of producing the same |
| 12/29/1994 | CA2126932A1 Semi-solid pharmaceutical composition comprising an anhydrous oligosaccharide and process to produce the same |
| 12/29/1994 | CA2126519A1 Nutritional supplement for calving ruminant animals |
| 12/28/1994 | EP0630651A2 Semi-solid pharmaceutical agent and process to produce the same |
| 12/28/1994 | EP0630650A1 Preparation for skin and mucoses containing nitric acid |
| 12/28/1994 | EP0630646A1 Controlled-release formulations coated with aqueous dispersions of ethylcellulose |
| 12/28/1994 | EP0630644A1 Anti-microbial and interferon-inducing pharmaceutical compound |
| 12/28/1994 | EP0630411A1 Method for enzymatically synthesizing peptide alkyl esters, resulting products and use thereof |
| 12/28/1994 | EP0630383A1 Methods of treating diabetes |
| 12/28/1994 | EP0630287A1 Microcapsules with primary alcohol functions containing polysaccharide walls and compositions containing them. |
| 12/28/1994 | EP0630275A1 Fibrin sealant delivery method |
| 12/28/1994 | EP0630263A1 Pharmaceutical composition having site-specific delivery |
| 12/28/1994 | EP0630262A1 Compositions for controlled delivery of pharmaceutical compounds |
| 12/28/1994 | EP0630261A1 New cyclodextrins and new formulated drugs |
| 12/28/1994 | EP0630260A1 Polysaccharide-protein conjugates |
| 12/28/1994 | EP0630247A1 Topical compositions containing steroids |
| 12/28/1994 | EP0630238A1 Reducing post-prandial fluctuations in plasma concentrations of large neutral amino acids (lnaa) |
| 12/28/1994 | EP0630236A1 Self-assembling diketopiperazine drug delivery system. |
| 12/28/1994 | EP0630234A1 Controlled release acth containing microspheres. |
| 12/28/1994 | EP0630230A1 Pharmaceutical inhalation compositions. |
| 12/28/1994 | EP0630229A1 Pressurized gas packagings using polyoxyethylene glyceryl-obates. |
| 12/28/1994 | EP0561821B1 Method of producing collagen particles, and the use of such particles as substrates for active substances |
| 12/28/1994 | EP0558525B1 Semduramicin premix |
| 12/28/1994 | EP0534995B1 Inclusion compounds of nimesulide with cyclodextrins |
| 12/28/1994 | EP0493441B1 Paucilamellar lipid vesicles using charge-localized, single chain, nonphospholipid surfactants |
| 12/28/1994 | CN1096700A Medicine for treating calculus |
| 12/28/1994 | CN1096687A Composite drug for reinforcing the kidney and supporting yang and its preparing method |
| 12/28/1994 | CN1096673A Injectable composition |
| 12/28/1994 | CN1027133C Dry adsorbates |
| 12/27/1994 | US5376693 Administering aqueous gel containing ionic polysaccharide, surfactant and crosslinkable polyether (having controlled pH and osmolality) |
| 12/27/1994 | US5376690 Metallospheres and superclusters |
| 12/27/1994 | US5376688 Hydroxide capable of dissociating into pharmaceutically acceptable cations and hydroxide ions and a solvent system |
| 12/27/1994 | US5376652 Administration of a 27-hydroxycholesterol or related compound or sterol-27-hydroxylase stimulant to prevent restenosis following vascular endothelial injury |
| 12/27/1994 | US5376646 Topical preparations containing the salt of a cholanic acid and a lipid |
| 12/27/1994 | US5376645 Derivatives of cyclodextrins exhibiting enhanced aqueous solubility and the use thereof |